Cbl-b-IN-16 (compound 31) is an orally active inhibitor of the RING E3 ligase Cbl-b, with an IC50 of 30 nM. It enhances IL-2 production in human T cells with an EC50 of 230 nM and exhibits antitumor activity.
Formula:
C26H27F3N6O
Target:
E1/E2/E3 Enzyme
* VAT and and shipping costs not included. Errors and price changes excepted